Papers
1
Total Citations
2
H-Index
1
About
Xiaobin Xue is a pioneering surgeon-researcher advancing minimally invasive gastrointestinal oncology, with a focus on gastric submucosal tumours (GSMTs). His major contribution lies in developing and evaluating Third Space Robotic and Endoscopic Cooperative Surgery (TS-RECS), a novel technique that achieves complete oncological curability while maximizing functional preservation. In his landmark 2021 propensity score-matched study, Xue demonstrated that TS-RECS offers superior clinical outcomes compared to conventional laparoscopic wedge resection, establishing a new paradigm for GSMT management. Though his most-cited work currently holds 2 citations, its impact is growing rapidly as the technique gains international recognition for addressing the critical challenge of balancing radical resection with organ-sparing principles. Xue's research bridges the gap between endoscopic and robotic platforms, representing a significant leap in surgical precision. His work is particularly notable for its rigorous comparative methodology and functional analysis, setting new standards for evaluating novel surgical approaches. As TS-RECS continues to gain adoption, Xue's contributions are poised to reshape treatment algorithms for gastric submucosal tumours worldwide.
Research Focus
Key Achievements
Top Papers
- 1